Response to dexamethasone is glucose-sensitive in multiple myeloma cell lines

Journal of Experimental and Clinical Cancer Research

Volumn 30, Issue 1, 2011, Pages

  Friday, Ellen ^a   Ledet, Johnathan ^a   Turturro, Francesco ^a,b  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; GLUCOSE; REACTIVE OXYGEN METABOLITE; RNA; THIOREDOXIN; THIOREDOXIN INTERACTING PROTEIN; ANTIINFLAMMATORY AGENT; CARRIER PROTEIN; MESSENGER RNA; SWEETENING AGENT; TXNIP PROTEIN, HUMAN;

ABSORPTION; ARTICLE; ASSAY; CELL PROLIFERATION; DOSE RESPONSE; GENE CONTROL; HUMAN; HUMAN CELL; HYPERGLYCEMIA; IC 50; MULTIPLE MYELOMA; MYELOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; DRUG ANTAGONISM; FLOW CYTOMETRY; GENETICS; METABOLISM; PATHOLOGY; TUMOR CELL CULTURE;

ANTI-INFLAMMATORY AGENTS; CARRIER PROTEINS; DEXAMETHASONE; FLOW CYTOMETRY; GLUCOSE; HUMANS; HYPERGLYCEMIA; MULTIPLE MYELOMA; REACTIVE OXYGEN SPECIES; RNA, MESSENGER; SWEETENING AGENTS; THIOREDOXINS; TUMOR CELLS, CULTURED;

EID: 80052689577     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-30-81     Document Type: Article

References (22)

1. Development of effective new treatments for multiple myeloma. Anderson KC, Pazdur R, Farrell AT, J Clin Oncol 2005 28 7207 7211
2. Phase III clinical trial of thalidomide plus dexamethasone compared with dexamethasone alone in newly diagnosed multiple myeloma: a clinical trial coordinated by the Eastern Cooperative Oncology Group. Rajkumar SV, Blood E, Vesole D, Fonseca R, Greipp PR, J Clin Oncol 2006 24 431 436 10.1200/JCO.2005.03.0221 16365178 (Pubitemid 46630462)
3. Lenalidomide plus dexamethasone versus thalidomide plus dexamethasone in newly diagnosed multiple myeloma: a comparative analysis of 411 patients. Gay F, Hayman SR, Lacy MQ, Buadi F, Gertz MA, Kumar S, Dispenzieri A, Mikhael JR, Bergasagel PL, Dingli D, Reeder CB, Lust JA, Russell SJ, Roy V, Zeldenrust SR, Witzig TE, Fonseca R, Kyle RA, Stewart AK, Rajkumar SV, Blood 2010 115 1343 1350 10.1182/blood-2009-08-239046 20008302
4. Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomized controlled trial. Rajkumar SV, Jacobs S, Callander NS, Fonseca R, Vesole DH, Williams ME, Abonour R, Siegel DS, Katz M, Greipp RR, Eastern Cooperative Oncology Group, Lancet Oncol 2010 11 29 37 10.1016/S1470-2045(09)70284-0 19853510
5. Hyperglycemia regulates thioredoxin-ROS activity through induction of thioredoxin-interacting protein (TXNIP) in metastatic breast cancer-derived cells MDA-MB-231. Turturro F, Friday E, Welbourne T, BMC Cancer 2007 7 96 102 10.1186/1471-2407-7-96 17555594 (Pubitemid 47054112)
6. Hyperglycemia-induced thioredoxin-interacting protein expression differs in breast cancer-derived cells and regulates paclitaxel IC50. Turturro F, Burton G, Friday E, Clin Cancer Res 2007 13 3724 3730 10.1158/1078-0432.CCR-07-0244 17575238 (Pubitemid 46955137)
7. Identification of thioredoxin-binding protein-2/vitamin D(3) up-regulated protein as a negative regulator of thioredoxin function and expression. Nishiyama A, Matsui M, Iwata S, Hirota K, Nakamura H, Takagi Y, Sono H, Gon Y, Yodoi J, J Biol Chem 1999 274 21645 21650 10.1074/jbc.274.31.21645 10419473 (Pubitemid 29359988)
8. Vitamin D3 up-regulated protein 1 mediates oxidative stress via suppressing the thioredoxin function. Junn E, Han SH, Im JY, Yang Y, Cho EW, Um HD, Kim DK, Lee KW, Han PL, Rhee SG, Choi I, J Immunol 2000 164 6287 6295 10843682 (Pubitemid 30408809)
9. Oligonucleotide microarray analysis of intact human pancreatic islets: identification of glucose-responsive genes and a highly regulated TGFbeta signaling pathway. Shalev A, Pise-Masison CA, Radonovich M, Hoffman SC, Hirshberg B, Brady JN, Harlan DM, Endocrinology 2002 143 3695 3698 10.1210/en.2002-220564 12193586 (Pubitemid 34925747)
10. Thioredoxin-interacting protein is stimulated by glucose through a carbohydrate response element and induces beta-cell apoptosis. Minn AH, Hafele C, Shalev A, Endocrinology 2005 146 2397 2405 10.1210/en.2004-1378 15705778 (Pubitemid 40577527)
11. Thioredoxin-interacting protein (txnip) is a glucocorticoid-regulated primary response gene involved in mediating glucocorticoid-induced apoptosis. Wang Z, Rong YP, Malone MH, Davis MC, Zhong F, Distelhorst CW, Oncogene 2006 23 1903 1913
12. Genomewide identification of prednisolone-responsive genes in acute lymphoblastic leukemia cells. Tissing WJ, den Boer ML, Meijerink JP, Menezes RX, Swagemakers S, van der Spek PJ, Sallan SE, Armstrong SA, Pieters R, Blood 2007 109 3229 3235
13. Gene expression profiling of leukemic cells and primary thymocytes predicts a signature for apoptotic sensitivity to glucocorticoids. Miller AL, Komak S, Webb MS, Leiter EH, Thompson EB, Cancer Cell Int 2007 7 18 10.1186/1475-2867-7-18 18045478 (Pubitemid 351242526)
14. The emerging role of the thioredoxin system in angiogenesis. Dunn LL, Buckle AM, Cooke JP, Ng MKC, Arterioscler Thromb Vasc Biol 2010 30 2089 2098 10.1161/ATVBAHA.110.209643 20798378
15. toremodeling in diabetic rat heart. Li X, Xu Z, Li S, Rozanski GJ, Am J Physiol Heart Circ Physiol 2005 288 1417 1424 15539426
16. Effect of thioredoxin reductase 1 on glucocorticoid receptor activity in human outer root sheath cells. Sohn KC, Jang S, Choi DK, Lee YS, Yoon TJ, Jeon EK, Kim KH, Seo YJ, Lee JH, Park JK, Kim CD, Biochem Byophys Res Commun 2007 356 810 815 10.1016/j.bbrc.2007.03.065 (Pubitemid 46499039)
17. Why do cancers have high high aerobic glycolysis. Gatenby RA, Gillies RJ, Nat Rev Cancer 2004 4 891 899 10.1038/nrc1478 15516961 (Pubitemid 39472955)
18. Glucose sensing by MondoA:Mix complexes: A role for exokinases and direct regulation of thioredoxin-interacting protein expression. Stoltzman CA, Peterson CW, Breen KT, Muoio DM, Billin AN, Ayer DE, Proc Natl Acad Sci USA 2008 105 6912 6917 10.1073/pnas.0712199105 18458340 (Pubitemid 351754504)
19. Glutamine-dependent anapleurosis dictates glucose uptake and cell growth by regulating MondoA transcriptional activity. Kaadige MR, Looper RE, Kamalanaadhan S, AyeR DE, Proc Natl Acad Sci USA 2009 106 14878 14883 10.1073/pnas.0901221106 19706488
20. Emerging pathways of non-genomic glucocorticoid (GC) signaling in T cells. Boldizsar F, Talaber G, Szabo M, Bartis D, Palinkas L, Nemeth P, Berki T, Immunobiology 2010 215 521 526 10.1016/j.imbio.2009.10.003 19906460
21. Dynamic regulation of mitochondrial function by glucocorticoids. Du J, Wang Y, Hunter R, Blumenthal R, Falke C, Khairova R, Zhou R, Yuan P, Machado-Vieira R, McEwen BS, Manji HK, Proc Natl Acad Sci USA 2009 106 3543 3548 10.1073/pnas.0812671106 19202080
22. Dexamethasone-induced oxidative stress enhances myeloma cell radiosensitization while sparing normal bone marrow hematopoiesis. Bera S, Greiner S, Choudhury A, Dispenzieri A, Spitz DR, Russell SJ, Goel A, Neoplasia 2010 12 980 992 21170263